Similarly, in prostate cancer, increased expression of SEMA3C in cancer cells was shown to upregulate epithelial to mesenchymal (EMT) markers, which was associated with increased migration and invasiveness and with increased tumour formation in mouse models [30]. The gene discussed is SEMA3C; the disease is neoplasm.